More than two million donut products have been recalled nationwide due to a potential contamination with dangerous bacteria.

Terra Wonsettler, PharmD, MBA, vice president of pharmacy for Evolent, discusses the recent HHS OIG report that stemmed from ...

AbbVie said on Friday that the U.S. Food and Drug Administration approved its drug for complicated intra-abdominal infections ...

A group of Senators has warned the FDA about an ad expected to air during Sunday’s big game that they believe misleads ...

Medically reviewed by Melissa Nieves, LND Magnesium is an essential mineral involved in more than 300 reactions in the body.

Yes, it’s safe to buy and eat chicken wings for the Super Bowl. Both the USDA and FDA are responsible for protecting public ...

The FDA has approved the intravenous antibiotic Emblaveo for adults with complicated intra-abdominal infections who have limited treatment options.

TCTMD spoke with Batchelor about how executive orders on DEI and federal funding are impacting the research ecosystem.

It's the first and only such therapy approved to fight antimicrobial resistance, or AMR, in bacterial infections.

However, we still see areas of weakness in the portfolio, including upcoming patent losses and a highly uncertain pipeline due to the complexities of running CNS trials. Historically, the firm ...

A device long used by adults to manage migraines was now available for children as young as eight years old, offering new ...

AbbVie received Food and Drug Administration approval of Emblaveo, an intravenous antibiotic, for treatment of adults with complicated intra-abdominal infections with limited or no treatment options.